FDA

John Eng, MD, was recently named as the latest winner of the Golden Goose Awards. Eng is the second winner announced in 2013, and others will be named in the coming weeks. The Golden Goose Award was created last year to celebrate researchers whose seemingly odd or obscure federally funded research turned out to have a significant, positive impact on society. Eng, a one-time researcher with the Veterans Administration in New York City, discovered that the venom contained in the bite of a Gila monster ’€” a lizard native to the southwest U.S. and northwest Mexico ’€” had components that could aid diabetics. His research was funded by the VA and built on previous studies funded by the National...
John Eng, MD, was recently named as the latest winner of the Golden Goose Awards. Eng is the second winner announced in 2013, and others will be named in the coming weeks. The Golden Goose Award was created last year to celebrate researchers whose seemingly odd or obscure federally funded research turned out to have a significant, positive impact on society. Eng, a one-time researcher with the Veterans Administration in New York City, discovered that the venom contained in the bite of a Gila monster ’€” a lizard native to the southwest U.S. and northwest Mexico ’€” had components that could aid diabetics. His research was funded by the VA and built on previous studies funded by the National...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Cyclospora cayetanensis Photo credit: CDC The Centers for Disease Control and Prevention is closely monitoring a new stomach bug that has hit several states. The one-celled parasite known as Cyclospora, which causes diarrhea, stomach cramps and other symptoms normally associated with a viral stomach bug, has sickened hundreds of people across the country. As of this week, the CDC has been notified of 285 cases of Cyclospora infection in 11 states including Iowa, Nebraska, Texas, Wisconsin, Georgia, Connecticut, New Jersey, Minnesota and Ohio. At least 18 persons reportedly have been hospitalized in three states with most of the illnesses surfacing between mid-June through early July. The...
Cyclospora cayetanensis Photo credit: CDC The Centers for Disease Control and Prevention is closely monitoring a new stomach bug that has hit several states. The one-celled parasite known as Cyclospora, which causes diarrhea, stomach cramps and other symptoms normally associated with a viral stomach bug, has sickened hundreds of people across the country. As of this week, the CDC has been notified of 285 cases of Cyclospora infection in 11 states including Iowa, Nebraska, Texas, Wisconsin, Georgia, Connecticut, New Jersey, Minnesota and Ohio. At least 18 persons reportedly have been hospitalized in three states with most of the illnesses surfacing between mid-June through early July. The...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor